Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Rostami

Showing results (181-190 of 199) with videos related to

Pageof 20
Sort By:
Annals of the New York Academy of Sciences|December 10, 1999
Schwann cell apoptosis during cell-mediated demyelinationG Conti, E Scarpini, A Rostami, et al.
Clinical Immunology (Orlando, Fla.)|January 6, 2001
Modulation of susceptibility and resistance to an autoimmune model of multiple sclerosis in prototypically susceptible and resistant strains by neutralization of interleukin-12 and interleukin-4, respectivelyC S Constantinescu, B Hilliard, E Ventura, et al.
Clinical Pharmacology and Therapeutics|January 23, 2016
Systematic and quantitative assessment of the effect of chronic kidney disease on CYP2D6 and CYP3A4/5K Yoshida, B Sun, L Zhang, et al.
International Journal of Environmental Research and Public Health|August 29, 2017
Determination of Selected Chemical Levels in Room Air and on Surfaces after the Use of Cartridge- and Tank-Based E-Vapor Products or Conventional CigarettesJianmin Liu, Qiwei Liang, Michael J Oldham, et al.
Clinical Pharmacology and Therapeutics|April 17, 2013
A physiologically based pharmacokinetic modeling approach to predict disease-drug interactions: suppression of CYP3A by IL-6K K Machavaram, L M Almond, A Rostami-Hodjegan, et al.
CPT: Pharmacometrics & Systems Pharmacology|July 27, 2013
From Pediatric Covariate Model to Semiphysiological Function for Maturation: Part II-Sensitivity to Physiological and Physicochemical PropertiesE H J Krekels, T N Johnson, S M den Hoedt, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|March 29, 2016
Metformin and cimetidine: Physiologically based pharmacokinetic modelling to investigate transporter mediated drug-drug interactionsH J Burt, S Neuhoff, L Almond, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|July 1, 1996
Similar physiological and symptomatic responses to sulphonylurea and insulin induced hypoglycaemia in normal subjectsS R Peacey, E George, A Rostami-Hodjegan, et al.
British Journal of Clinical Pharmacology|August 5, 2003
A discordance between cytochrome P450 2D6 genotype and phenotype in patients undergoing methadone maintenance treatmentM R Shiran, J Chowdry, A Rostami-Hodjegan, et al.
British Journal of Clinical Pharmacology|October 6, 1999
The antitussive effect of dextromethorphan in relation to CYP2D6 activityR Abdul Manap, C E Wright, A Gregory, et al.
Pageof 20

Showing results (181-190 of 199) with videos related to

Sort By:
Pageof 20
Annals of the New York Academy of Sciences|December 10, 1999
Schwann cell apoptosis during cell-mediated demyelinationG Conti, E Scarpini, A Rostami, et al.
Clinical Immunology (Orlando, Fla.)|January 6, 2001
Modulation of susceptibility and resistance to an autoimmune model of multiple sclerosis in prototypically susceptible and resistant strains by neutralization of interleukin-12 and interleukin-4, respectivelyC S Constantinescu, B Hilliard, E Ventura, et al.
Clinical Pharmacology and Therapeutics|January 23, 2016
Systematic and quantitative assessment of the effect of chronic kidney disease on CYP2D6 and CYP3A4/5K Yoshida, B Sun, L Zhang, et al.
International Journal of Environmental Research and Public Health|August 29, 2017
Determination of Selected Chemical Levels in Room Air and on Surfaces after the Use of Cartridge- and Tank-Based E-Vapor Products or Conventional CigarettesJianmin Liu, Qiwei Liang, Michael J Oldham, et al.
Clinical Pharmacology and Therapeutics|April 17, 2013
A physiologically based pharmacokinetic modeling approach to predict disease-drug interactions: suppression of CYP3A by IL-6K K Machavaram, L M Almond, A Rostami-Hodjegan, et al.
CPT: Pharmacometrics & Systems Pharmacology|July 27, 2013
From Pediatric Covariate Model to Semiphysiological Function for Maturation: Part II-Sensitivity to Physiological and Physicochemical PropertiesE H J Krekels, T N Johnson, S M den Hoedt, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|March 29, 2016
Metformin and cimetidine: Physiologically based pharmacokinetic modelling to investigate transporter mediated drug-drug interactionsH J Burt, S Neuhoff, L Almond, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|July 1, 1996
Similar physiological and symptomatic responses to sulphonylurea and insulin induced hypoglycaemia in normal subjectsS R Peacey, E George, A Rostami-Hodjegan, et al.
British Journal of Clinical Pharmacology|August 5, 2003
A discordance between cytochrome P450 2D6 genotype and phenotype in patients undergoing methadone maintenance treatmentM R Shiran, J Chowdry, A Rostami-Hodjegan, et al.
British Journal of Clinical Pharmacology|October 6, 1999
The antitussive effect of dextromethorphan in relation to CYP2D6 activityR Abdul Manap, C E Wright, A Gregory, et al.
Pageof 20